Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1441 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.100 | 0.913 | 23 | 2011 | 2019 | ||||
Primary malignant neoplasm
|
1374 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.100 | 0.913 | 23 | 2011 | 2019 | ||||
Liver carcinoma
|
769 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.100 | 0.895 | 19 | 2011 | 2019 | ||||
Breast Carcinoma
|
2145 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.100 | 0.929 | 14 | 2009 | 2017 | ||||
Malignant neoplasm of breast
|
2154 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.100 | 0.857 | 14 | 2009 | 2017 | ||||
Rheumatoid Arthritis
|
676 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.100 | 0.833 | 12 | 2011 | 2019 | ||||
Ischemic stroke
|
586 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.080 | 0.875 | 8 | 2014 | 2019 | ||||
Malignant neoplasm of lung
|
1000 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.060 | 0.833 | 6 | 2014 | 2018 | ||||
Carcinoma of lung
|
995 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.050 | 0.800 | 5 | 2014 | 2018 | ||||
Coronary Artery Disease
|
1022 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.050 | 0.800 | 5 | 2012 | 2019 | ||||
Coronary heart disease
|
769 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.050 | 1.000 | 5 | 2009 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.050 | 0.800 | 5 | 2014 | 2018 | ||||
Colorectal Carcinoma
|
1186 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.040 | 1.000 | 4 | 2012 | 2016 | ||||
Lupus Erythematosus, Systemic
|
635 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.030 | 1.000 | 3 | 2011 | 2017 | ||||
Malignant neoplasm of prostate
|
861 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.030 | 1.000 | 3 | 2015 | 2019 | ||||
Malignant neoplasm of stomach
|
603 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.030 | 1.000 | 3 | 2010 | 2015 | ||||
Non-Small Cell Lung Carcinoma
|
601 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.030 | 1.000 | 3 | 2011 | 2019 | ||||
Prostate carcinoma
|
858 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.030 | 1.000 | 3 | 2015 | 2019 | ||||
Renal Cell Carcinoma
|
182 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.030 | 1.000 | 3 | 2014 | 2018 | ||||
Asthma
|
714 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.020 | 0.500 | 2 | 2011 | 2017 | ||||
Autoimmune Diseases
|
213 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||
Bladder Neoplasm
|
278 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||
Carcinogenesis
|
355 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.020 | 0.500 | 2 | 2011 | 2015 | ||||
Carcinoma of bladder
|
290 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||
cervical cancer
|
257 | 0.514 | 0.760 | 20 | 34990448 | mature miRNA variant | A/G | snv | 0.20 | 0.19 | 0.020 | 1.000 | 2 | 2019 | 2019 |